Cell and Gene Therapy Bio-manufacturing Market Size, Share & Trends Analysis Report By Product Type (Consumables, Equipment, And Software Solutions), Usage (Commercial-Stage Manufacturing And Research-Stage Manufacturing), Application (Upstream Processing, Harvesting, And Downstream Processing), And End-User, By Region, And Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Cell and Gene Therapy Biomanufacturing Market Snapshot Chapter 4. Global Cell and Gene Therapy Biomanufacturing Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis 5.1. by Product & Market Share, 2024 & 2034 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product: 5.2.1. Consumables 5.2.1.1. Culture Supplements 5.2.1.1.1. Media 5.2.1.1.2. Serum 5.2.1.1.3. Macronutrients 5.2.1.2. Single-Use Liquids 5.2.1.3. Cell Culture Reagents 5.2.1.4. Cell Quantification Kits 5.2.2. Equipment 5.2.2.1. Bioreactors/Fermenters 5.2.2.1.1. Continuous Bioreactors 5.2.2.1.2. Single-Use Bioreactors 5.2.2.2. Mixing Systems 5.2.2.3. Cell Counters 5.2.2.4. Cell Sorters 5.2.2.5. Centrifuges 5.2.2.6. Incubators 5.2.2.7. Biosafety Cabinets 5.2.2.8. Freezers 5.2.2.9. PCR Systems 5.2.2.10. Transfection Systems 5.2.2.11. Storage Tanks 5.2.2.12. Others 5.2.3. Software Solutions Chapter 6. Market Segmentation 2: by Usage Estimates & Trend Analysis 6.1. by Usage & Market Share, 2024 & 2034 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Usage: 6.2.1. Commercial Stage Manufacturing 6.2.2. Research Stage Manufacturing Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis 7.1. by Application & Market Share, 2024 & 2034 7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application: 7.2.1. Upstream Processing 7.2.1.1. Formulation and Hydration 7.2.1.2. Cell Culture Processing 7.2.2. Harvesting 7.2.3. Downstream Processing 7.2.3.1. Separation and Filtration 7.2.3.2. Fill and Finish Operations Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis 8.1. by End-user & Market Share, 2024 & 2034 8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user: 8.2.1. Life Science Companies 8.2.1.1. Equipment 8.2.1.2. Consumables 8.2.1.3. Software Solutions 8.2.2. Contract Research Organizations (CROs) 8.2.2.1. Equipment 8.2.2.2. Consumables 8.2.2.3. Software Solutions 8.2.3. Contract Manufacturing Organizations (CMOs) 8.2.3.1. Equipment 8.2.3.2. Consumables 8.2.3.3. Software Solutions 8.2.4. Cell Banks 8.2.4.1. Equipment 8.2.4.2. Consumables 8.2.4.3. Software Solutions Chapter 9. Cell and Gene Therapy Biomanufacturing Market Segmentation 5: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034 9.1.2. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034 9.1.3. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.1.4. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 9.1.5. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 9.2. Europe 9.2.1. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034 9.2.2. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034 9.2.3. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.2.4. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 9.2.5. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 9.3. Asia Pacific 9.3.1. Asia Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034 9.3.2. Asia Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034 9.3.3. Asia-Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.3.4. Asia-Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 9.3.5. Asia Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 9.4. Latin America 9.4.1. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034 9.4.2. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034 9.4.3. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.4.4. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 9.4.5. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 9.5. Middle East & Africa 9.5.1. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034 9.5.2. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034 9.5.3. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.5.4. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 9.5.5. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 Chapter 10. Competitive Landscape 10.1. Major Mergers and Acquisitions/Strategic Alliances 10.2. Company Profiles 10.2.1. Becton, Dickinson and Company 10.2.2. Endress+Hauser Group Services AG (Analytik Jena GmbH) 10.2.3. Danaher Corporation 10.2.4. Bio-Rad Laboratories, Inc. 10.2.5. Bio-Techne Corporation 10.2.6. General Electric Company (G.E. Healthcare) 10.2.7. Getinge AB 10.2.8. Infors AG 10.2.9. Lonza Group Ltd 10.2.10. Merck KGaA 10.2.11. Miltenyi Biotec B.V. & Co. KG 10.2.12. PIERRE GUERIN 10.2.13. Sartorius AG (Sartorius Stedim Biotech S.A.) 10.2.14. Thermo Fisher Scientific Inc. 10.2.15. WuXi AppTec 10.2.16. Other Prominent Players